Everett E. Vokes

Proteomic characterization of non-small cell lung cancer in a comprehensive translational thoracic oncology database

Eneida A. Mendonça, Ravi Salgia, Rifat Hasina, 2011, Journal of Clinical Bioinformatics.

Comprehensive genetic testing identifies targetable genomic alterations in most patients with non-small cell lung cancer, specifically adenocarcinoma, single institute investigation

Heber MacMahon, Ravi Salgia, Everett E. Vokes, 2016, Oncotarget.

Genomic profiling of kinase genes in head and neck squamous cell carcinomas to identify potentially targetable genetic aberrations in FGFR1/2, DDR2, EPHA2, and PIK3CA.

Kevin P. White, Christopher D. Brown, Ralph R. Weichselbaum, 2013 .

Integrative Analysis of Head and Neck Cancer Identifies Two Biologically Distinct HPV and Three Non-HPV Subtypes

Kevin P. White, Christopher D. Brown, Damian Rieke, 2014, Clinical Cancer Research.

CBL Is Frequently Altered in Lung Cancers: Its Relationship to Mutations in MET and EGFR Tyrosine Kinases

Ravi Salgia, Rifat Hasina, Kenan Onel, 2010, PloS one.

Oncologic Therapies

Everett E. Vokes, E. Vokes, H. Golomb, 2003, Springer Berlin Heidelberg.

Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer.

Olufunmilayo I. Olopade, Mark W. Lingen, Everett E. Vokes, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Integrative and Comparative Genomic Analysis of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinomas

Petar Stojanov, Kevin P. White, Christopher D. Brown, 2014, Clinical Cancer Research.

Head and neck cancer in 2010: Maximizing survival and minimizing toxicity

Everett E. Vokes, E. Vokes, Bruce E. Brockstein, 2011, Nature Reviews Clinical Oncology.

Effect of the addition of temsirolimus to cetuximab in cetuximab-resistant head and neck cancers: Results of the randomized PII MAESTRO study.

Yves A. Lussier, Walter M. Stadler, Apoorva Chawla, 2014 .